omeprazole has been researched along with Dysphagia in 41 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In controlled clinical trials, rabeprazole effectively improves symptoms and heals oesophageal erosions in patients with gastro-oesophageal reflux disease (GORD)." | 9.11 | Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study. ( Archimandritis, AJ; Avgerinos, A; Kouklakis, G; Nikolopoulou, V; Paraskevas, E; Triantafillidis, JK; Tsianos, E, 2005) |
| "Empiric omeprazole therapy is a reasonable, initial approach to patients with suspected gastroesophageal reflux-related posterior laryngitis." | 7.69 | Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study. ( Delgaudio, JM; Grist, WJ; Gussack, G; Waring, JP; Wo, JM, 1997) |
| "Drug-induced esophagitis is an uncommon diagnosis in the pediatric population." | 5.56 | L-arginine-induced esophagitis, report of six cases. ( Casaubón-Garcín, PR; Ferreiro-Marin, A; González-Cruz, MÁ; Parra, PR, 2020) |
| " After appropriate assessment with esophageal manometry and 24 h ambulatory pHmetry, patients with documented gastroesophageal reflux disease (GERD) were treated with omeprazole continuously." | 5.12 | Single-session, graded esophageal dilation without fluoroscopy in outpatients with lower esophageal (Schatzki's) rings: a prospective, long-term follow-up study. ( Bergele, C; Mantides, A; Sgouros, SN; Stefanidis, G; Vassiliadis, K; Vlachogiannakos, J, 2007) |
| "In controlled clinical trials, rabeprazole effectively improves symptoms and heals oesophageal erosions in patients with gastro-oesophageal reflux disease (GORD)." | 5.11 | Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study. ( Archimandritis, AJ; Avgerinos, A; Kouklakis, G; Nikolopoulou, V; Paraskevas, E; Triantafillidis, JK; Tsianos, E, 2005) |
| "Heartburn, regurgitation and dysphagia were hardly found in any group at 8 weeks after 15 mg or 30 mg lansoprazole treatment." | 5.11 | Management of symptoms in step-down therapy of gastroesophageal reflux disease. ( Iida, T; Kishikawa, H; Mine, S; Tabata, T; Tanaka, Y, 2005) |
| "This study aimed to determine whether dysphagia associated with gastroesophageal reflux disease was effectively treated with rabeprazole, a proton pump inhibitor." | 5.11 | Dysphagia associated with gastroesophageal reflux disease is improved by proton pump inhibitor. ( Danjo, A; Fujimoto, K; Hara, M; Iwakiri, R; Kikkawa, A; Oda, K; Ootani, A; Sakata, H; Shimoda, R; Tsunada, S; Watanabe, K, 2005) |
| "In our study omeprazole was superior to either lansoprazole or pantoprazole in the maintenance treatment of complicated gastro-oesophageal reflux disease." | 5.08 | A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis. ( Diehl, KL; Geyer, P; Jaspersen, D; Martens, E; Schoeppner, H, 1998) |
| " Etiologic investigations led to the discovery of Giardiasis lamblia on duodenal biopsies and a long-term treatment with proton pump inhibitors (PPI) (omeprazole followed by esomeprazole), both being recently described as causal factors of hypomagnesemic hypoparathyroidism." | 3.74 | [Chronic use of proton-pump inhibitors associated with giardiasis: A rare cause of hypomagnesemic hypoparathyroidism?]. ( Caron, J; Durlach, V; François, M; Lévy-Bohbot, N, 2008) |
| "Empiric omeprazole therapy is a reasonable, initial approach to patients with suspected gastroesophageal reflux-related posterior laryngitis." | 3.69 | Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study. ( Delgaudio, JM; Grist, WJ; Gussack, G; Waring, JP; Wo, JM, 1997) |
| "Eosinophilic esophagitis was diagnosed based on initial endoscopic biopsies and persistent eosinophilic inflammation despite PPI therapy." | 2.77 | Conservative long-term treatment of children with eosinophilic esophagitis. ( Edelman, M; Lai, J; Levine, J; Schuval, SJ, 2012) |
| " Novel dosage formulations of lansoprazole that may be appropriate for patients with dysphagia include the commercially manufactured lansoprazole strawberry-flavored enteric-coated granules for suspension and lansoprazole orally disintegrating tablets." | 2.42 | Management of acid-related disorders in patients with dysphagia. ( Howden, CW, 2004) |
| "Prednisone was continued with a slow taper, and after 1 month ber dysphagia had resolved and her esophageal manometry was normal." | 2.39 | Reversible esophageal motility disorder in a patient with sarcoidosis. ( Criss, DG; Geissinger, BW; Sharkey, MF; Wu, WC, 1996) |
| "Drug-induced esophagitis is an uncommon diagnosis in the pediatric population." | 1.56 | L-arginine-induced esophagitis, report of six cases. ( Casaubón-Garcín, PR; Ferreiro-Marin, A; González-Cruz, MÁ; Parra, PR, 2020) |
| "Although the key features of eosinophilic esophagitis have been increasingly described over recent years, this entity is still often not considered and consequently diagnosis is often either not made or delayed." | 1.38 | Eosinophilic esophagitis and food impaction: an instructive case. ( Day, A; Lemberg, D; Tilakaratne, S, 2012) |
| "Eight patients (17%) with relapse of dysphagia were referred to laparoscopic Heller myotomy with no surgical complication." | 1.36 | Combined treatment of achalasia - botulinum toxin injection followed by pneumatic dilatation: long-term results. ( Dolina, J; Hep, A; Kroupa, R; Matyasova, Z; Mrazova, J; Novotny, I; Prokesova, J; Sedmik, J; Valek, V, 2010) |
| " The literature suggests three possibilities to explain the inadequacy of the substitution: (a) biphasic metabolism where the raised pH in the stomach may prematurely inactivate the PPI, with an unpredictable effect, (b) differences in acid-resistant coating of the generic products, and (c) influence of multiple dosing of PPIs after several days' use." | 1.35 | [Why some proton pump inhibitors are more equal than others]. ( Lekkerkerker, JF; Mulder, CJ; Otten, MH, 2009) |
| "Recent studies suggest that gastroesophageal reflux disease (GERD) may be a major cause of globus sensation." | 1.32 | Globus sensation and gastroesophageal reflux. ( Brossard, E; Chevalier, JM; Monnier, P, 2003) |
| "In the dysphagia group, 48 of 54 patients (89%) had edema of the posterior larynx, and 42 of 54 (78%) had laryngopharyngeal sensory deficits." | 1.31 | Laryngopharyngeal sensory deficits in patients with laryngopharyngeal reflux and dysphagia. ( Aviv, JE; Close, LG; Kaplan, ST; Liu, H; Parides, M, 2000) |
| "Medical therapy fails to control gastroesophageal reflux as it does not inhibit regurgitation." | 1.30 | The effect of medical therapy and antireflux surgery on dysphagia in patients with gastroesophageal reflux disease without esophageal stricture. ( Gadenstaetter, M; Glaser, K; Hinder, RA; Profanter, C; Wetscher, GJ, 1999) |
| "We believe gastroesophageal reflux disease is an important factor in the cause of cervical problems." | 1.29 | Role of gastroesophageal reflux disease in patients with cervical symptoms. ( Freeman, J; Goldberg, M; Mendelsohn, M; Rival, R; Rosgen, S; Wong, R, 1995) |
| "A rare case of dysphagia caused by leiomyomatosis of the esophagus is presented." | 1.29 | [Leiomyomatosis of the esophagus]. ( Grönniger, J; Hillemanns, A; Oglodek, C; Reinbold, WD, 1994) |
| "We report an unusual presentation of gastroesophageal reflux disease in a 14-yr-old boy with cervical dysphagia and vomiting immediately after swallowing." | 1.29 | Unusual presentation of mucosal hypersensitivity secondary to gastroesophageal reflux disease. ( Andres, JM; Baron, TH; Richter, JE; Singh, S; Tennyson, GS, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (31.71) | 18.2507 |
| 2000's | 18 (43.90) | 29.6817 |
| 2010's | 8 (19.51) | 24.3611 |
| 2020's | 2 (4.88) | 2.80 |
| Authors | Studies |
|---|---|
| Posner, S | 1 |
| Boyd, A | 1 |
| Patel, A | 1 |
| Parra, PR | 1 |
| González-Cruz, MÁ | 1 |
| Ferreiro-Marin, A | 1 |
| Casaubón-Garcín, PR | 1 |
| Beales, ILP | 1 |
| Toseef, MU | 1 |
| Saeed, A | 1 |
| Mohi-Ud-Din, E | 1 |
| Usmanghani, K | 1 |
| Nazar, H | 1 |
| Nawaz, A | 1 |
| Ahmad, I | 1 |
| Siddiqui, FA | 1 |
| Novak, SH | 1 |
| Shortsleeve, MJ | 1 |
| Kantrowitz, PA | 1 |
| Yadlapati, R | 1 |
| Pandolfino, JE | 1 |
| Lidder, AK | 1 |
| Shabeeb, N | 1 |
| Jaiyeola, DM | 1 |
| Adkins, C | 1 |
| Agrawal, N | 1 |
| Cooper, A | 1 |
| Price, CP | 1 |
| Ciolino, JD | 1 |
| Gawron, AJ | 1 |
| Smith, SS | 1 |
| Bove, M | 1 |
| Tan, BK | 1 |
| François, M | 1 |
| Lévy-Bohbot, N | 1 |
| Caron, J | 1 |
| Durlach, V | 1 |
| Kroupa, R | 1 |
| Hep, A | 1 |
| Dolina, J | 1 |
| Valek, V | 1 |
| Matyasova, Z | 1 |
| Prokesova, J | 1 |
| Mrazova, J | 1 |
| Sedmik, J | 1 |
| Novotny, I | 1 |
| Otten, MH | 1 |
| Lekkerkerker, JF | 1 |
| Mulder, CJ | 1 |
| De Rocker, H | 1 |
| Manabe, N | 1 |
| Haruma, K | 1 |
| Ito, M | 1 |
| Takahashi, N | 1 |
| Takasugi, H | 1 |
| Wada, Y | 1 |
| Nakata, H | 1 |
| Katoh, T | 1 |
| Miyamoto, M | 1 |
| Tanaka, S | 1 |
| Levine, J | 1 |
| Lai, J | 1 |
| Edelman, M | 1 |
| Schuval, SJ | 1 |
| Tilakaratne, S | 1 |
| Day, A | 1 |
| Lemberg, D | 1 |
| Chevalier, JM | 1 |
| Brossard, E | 1 |
| Monnier, P | 1 |
| Füessl, HS | 1 |
| Ibrahim, A | 1 |
| Cole, RA | 1 |
| Qureshi, WA | 1 |
| Helaly, AZ | 1 |
| Jamecci, A | 1 |
| Graham, DY | 1 |
| Ayub, K | 1 |
| Howden, CW | 1 |
| Cornish, P | 1 |
| Archimandritis, AJ | 1 |
| Nikolopoulou, V | 1 |
| Kouklakis, G | 1 |
| Paraskevas, E | 1 |
| Avgerinos, A | 1 |
| Tsianos, E | 1 |
| Triantafillidis, JK | 1 |
| Mine, S | 1 |
| Iida, T | 1 |
| Tabata, T | 1 |
| Kishikawa, H | 1 |
| Tanaka, Y | 1 |
| Oda, K | 1 |
| Iwakiri, R | 1 |
| Hara, M | 1 |
| Watanabe, K | 1 |
| Danjo, A | 1 |
| Shimoda, R | 1 |
| Kikkawa, A | 1 |
| Ootani, A | 1 |
| Sakata, H | 1 |
| Tsunada, S | 1 |
| Fujimoto, K | 1 |
| Teraishi, F | 1 |
| Fujiwara, T | 1 |
| Jikuhara, A | 1 |
| Kamitani, S | 1 |
| Morino, Y | 1 |
| Sato, K | 1 |
| Tanaka, N | 1 |
| Anandasabapathy, S | 1 |
| Jaffin, BW | 1 |
| Sgouros, SN | 1 |
| Vassiliadis, K | 1 |
| Bergele, C | 1 |
| Vlachogiannakos, J | 1 |
| Stefanidis, G | 1 |
| Mantides, A | 1 |
| McBride, MA | 1 |
| Vanagunas, AA | 1 |
| Breshnahan, JP | 1 |
| Barch, DB | 1 |
| Rival, R | 1 |
| Wong, R | 1 |
| Mendelsohn, M | 1 |
| Rosgen, S | 1 |
| Goldberg, M | 1 |
| Freeman, J | 1 |
| Su, AY | 1 |
| Huggins, TL | 1 |
| Purdue, GF | 1 |
| Harford, WV | 1 |
| Reinbold, WD | 1 |
| Oglodek, C | 1 |
| Hillemanns, A | 1 |
| Grönniger, J | 1 |
| Jerome-Zapadka, KM | 1 |
| Clarke, MR | 1 |
| Sekas, G | 1 |
| Shoenut, JP | 1 |
| Wieler, JA | 1 |
| Micflikier, AB | 1 |
| Baron, TH | 1 |
| Richter, JE | 1 |
| Singh, S | 2 |
| Tennyson, GS | 1 |
| Andres, JM | 1 |
| Tibbling, L | 1 |
| Geissinger, BW | 1 |
| Sharkey, MF | 1 |
| Criss, DG | 1 |
| Wu, WC | 1 |
| McDougall, NI | 1 |
| Johnston, BT | 1 |
| Kee, F | 1 |
| Collins, JS | 1 |
| McFarland, RJ | 1 |
| Love, AH | 1 |
| Wo, JM | 1 |
| Grist, WJ | 1 |
| Gussack, G | 1 |
| Delgaudio, JM | 1 |
| Waring, JP | 1 |
| Jaspersen, D | 1 |
| Diehl, KL | 1 |
| Schoeppner, H | 1 |
| Geyer, P | 1 |
| Martens, E | 1 |
| Wetscher, GJ | 1 |
| Glaser, K | 1 |
| Gadenstaetter, M | 1 |
| Profanter, C | 1 |
| Hinder, RA | 1 |
| Grahn, LT | 1 |
| Aviv, JE | 1 |
| Liu, H | 1 |
| Parides, M | 1 |
| Kaplan, ST | 1 |
| Close, LG | 1 |
| Mallak, A | 1 |
| Bourienne, A | 1 |
| Pagenault, M | 1 |
| Bretagne, JF | 1 |
| Chattopadhyay, A | 1 |
| Sood, A | 1 |
| Wanchu, A | 1 |
| Bambery, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study[NCT02081404] | 98 participants (Actual) | Interventional | 2009-03-01 | Completed | |||
| Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study[NCT01574573] | 52 participants (Actual) | Interventional | 2009-06-30 | Terminated (stopped due to Closed due to lack of recruitment) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for omeprazole and Dysphagia
| Article | Year |
|---|---|
Management of acid-related disorders in patients with dysphagia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Age Factors; Aged; Aged, 80 an | 2004 |
Esophageal tissue band transected with hot biopsy forceps.
Topics: Biopsy; Combined Modality Therapy; Deglutition Disorders; Dilatation; Esophagitis, Peptic; Esophagos | 1995 |
Recurrent upper esophageal webs in association with heterotopic gastric mucosa: case report and literature review.
Topics: Aged; Barrett Esophagus; Deglutition Disorders; Esophagoscopy; Esophagus; Female; Follow-Up Studies; | 1994 |
Reversible esophageal motility disorder in a patient with sarcoidosis.
Topics: Adult; Deglutition Disorders; Drug Therapy, Combination; Esophageal Motility Disorders; Esophagus; F | 1996 |
9 trials available for omeprazole and Dysphagia
| Article | Year |
|---|---|
Comparative clinical evaluation on herbal formulation Pepsil, Safoof-e-Katira and Omeprazole in gastro esophageal reflux disease.
Topics: Astragalus gummifer; Coriandrum; Deglutition Disorders; Female; Gastroesophageal Reflux; Heartburn; | 2015 |
Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial.
Topics: Adult; Aged; Alginates; Deglutition Disorders; Drug Therapy, Combination; Female; Gastroesophageal R | 2012 |
Conservative long-term treatment of children with eosinophilic esophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Child; Child, Preschool; Deglutition Disorders; Endoscopy; | 2012 |
Schatzki's ring: to cut or break an unresolved problem.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Deglutition Disorders; Dilatation; Electrosurgery; En | 2004 |
Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Anti-Ulcer Agents; Benzi | 2005 |
Management of symptoms in step-down therapy of gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Deglutition Disorders; Endosonography; Enzyme Inhibit | 2005 |
Dysphagia associated with gastroesophageal reflux disease is improved by proton pump inhibitor.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Benzimidazoles; Deglutition Disord | 2005 |
Single-session, graded esophageal dilation without fluoroscopy in outpatients with lower esophageal (Schatzki's) rings: a prospective, long-term follow-up study.
Topics: Aged; Ambulatory Care; Deglutition Disorders; Dilatation; Enzyme Inhibitors; Esophageal Stenosis; Es | 2007 |
A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Deglutition | 1998 |
28 other studies available for omeprazole and Dysphagia
| Article | Year |
|---|---|
Dysphagia in a 34-Year-Old Woman.
Topics: Adult; Biopsy; Deglutition Disorders; Endoscopy, Digestive System; Eosinophilic Esophagitis; Esophag | 2020 |
L-arginine-induced esophagitis, report of six cases.
Topics: Adolescent; Arginine; Chest Pain; Child; Deglutition Disorders; Esophageal Mucosa; Esophagitis; Fema | 2020 |
Successful Treatment of Refractory Lymphocytic Esophagitis With Vedolizumab.
Topics: Adult; Antibodies, Monoclonal, Humanized; Budesonide; Deglutition Disorders; Endoscopy, Digestive Sy | 2019 |
Effective Treatment of Symptomatic Lower Esophageal (Schatzki) Rings With Acid Suppression Therapy: Confirmed on Barium Esophagography.
Topics: Adult; Aged; Aged, 80 and over; Barium Sulfate; Contrast Media; Deglutition Disorders; Esophagus; Fe | 2015 |
Oropharyngeal pH Testing Does Not Predict Response to Proton Pump Inhibitor Therapy in Patients with Laryngeal Symptoms.
Topics: Adult; Chronic Disease; Cohort Studies; Cough; Deglutition Disorders; Female; Hoarseness; Humans; Hy | 2016 |
[Chronic use of proton-pump inhibitors associated with giardiasis: A rare cause of hypomagnesemic hypoparathyroidism?].
Topics: Deglutition Disorders; Duodenum; Esomeprazole; Female; Giardiasis; Humans; Hypocalcemia; Hypoparathy | 2008 |
Combined treatment of achalasia - botulinum toxin injection followed by pneumatic dilatation: long-term results.
Topics: Adult; Aged; Aged, 80 and over; Botulinum Toxins, Type A; Catheterization; Cohort Studies; Combined | 2010 |
[Why some proton pump inhibitors are more equal than others].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Deglutition Disorders; Drugs, Generic; Female; Gastroesopha | 2009 |
[The administration of proton-pump inhibitors in little children or patients with difficulties in deglutition].
Topics: Administration, Oral; Administration, Rectal; Adolescent; Adult; Child; Child, Preschool; Deglutitio | 2009 |
Eosinophilic esophagitis and food impaction: an instructive case.
Topics: Adolescent; Androstadienes; Anti-Inflammatory Agents; Anti-Ulcer Agents; Deglutition Disorders; Drug | 2012 |
Globus sensation and gastroesophageal reflux.
Topics: Adult; Aged; Deglutition Disorders; Diagnostic Techniques, Digestive System; Enzyme Inhibitors; Fema | 2003 |
[Heartburn without esophagitis. Symptoms more important than the finding?].
Topics: Androstadienes; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ul | 2003 |
"Avoid the crush": hazards of medication administration in patients with dysphagia or a feeding tube.
Topics: Aged; Analgesics, Opioid; Anti-Ulcer Agents; Deglutition Disorders; Delayed-Action Preparations; Ent | 2005 |
Esophageal intramural pseudodiverticulosis with esophageal strictures successfully treated with dilation therapy.
Topics: Aged; Antifungal Agents; Candidiasis; Catheterization; Chronic Disease; Deglutition Disorders; Diagn | 2006 |
Multichannel intraluminal impedance in the evaluation of patients with persistent globus on proton pump inhibitor therapy.
Topics: Adult; Aged; Case-Control Studies; Deglutition Disorders; Electric Impedance; Enzyme Inhibitors; Eso | 2006 |
Combined endoscopic thermal electrocoagulation with high dose omeprazole therapy in complicated heterotopic gastric mucosa of the esophagus.
Topics: Adult; Anti-Ulcer Agents; Barrett Esophagus; Combined Modality Therapy; Deglutition Disorders; Elect | 1995 |
Role of gastroesophageal reflux disease in patients with cervical symptoms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Barium Sulfate; Biopsy; Cineradiograp | 1995 |
[Leiomyomatosis of the esophagus].
Topics: Anti-Ulcer Agents; Biopsy; Cisapride; Combined Modality Therapy; Deglutition Disorders; Esophageal N | 1994 |
The extent and pattern of gastro-oesophageal reflux in patients with scleroderma oesophagus: the effect of low-dose omeprazole.
Topics: Adult; Aged; Deglutition Disorders; Dose-Response Relationship, Drug; Esophagus; Female; Gastroesoph | 1993 |
Unusual presentation of mucosal hypersensitivity secondary to gastroesophageal reflux disease.
Topics: Adolescent; Deglutition Disorders; Enteral Nutrition; Eosinophils; Esophagitis, Peptic; Esophagus; F | 1993 |
Wrong-way swallowing as a possible cause of bronchitis in patients with gastroesophageal reflux disease.
Topics: Bronchitis; Chronic Disease; Cough; Deglutition Disorders; Female; Gastroesophageal Reflux; Hernia, | 1993 |
Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Barrett Esophagus; Cisapride; Deglutition Disorders; Disea | 1996 |
Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Barrett Esophagus; Cisapride; Deglutition Disorders; Disea | 1996 |
Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Barrett Esophagus; Cisapride; Deglutition Disorders; Disea | 1996 |
Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Barrett Esophagus; Cisapride; Deglutition Disorders; Disea | 1996 |
Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
Topics: Anti-Ulcer Agents; Cough; Deglutition Disorders; Female; Follow-Up Studies; Gastroesophageal Reflux; | 1997 |
The effect of medical therapy and antireflux surgery on dysphagia in patients with gastroesophageal reflux disease without esophageal stricture.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cisapride; | 1999 |
Longitudinal oesophageal muscle and pharyngo-oesophageal dysphagia--a deductive study.
Topics: Anti-Ulcer Agents; Bronchitis; Deglutition Disorders; Esophagogastric Junction; Esophagus; Gastroeso | 2000 |
Laryngopharyngeal sensory deficits in patients with laryngopharyngeal reflux and dysphagia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Deglutition Disorders; Fema | 2000 |
[Peptic stenosis of the colon: a rare complication of esophagocoloplasty].
Topics: Aged; Anastomosis, Surgical; Anti-Ulcer Agents; Colon; Constriction, Pathologic; Deglutition Disorde | 2000 |
Cervical osteophyte induced dysphagia.
Topics: Anti-Ulcer Agents; Cervical Vertebrae; Cisapride; Deglutition Disorders; Esophageal Stenosis; Gastro | 2001 |